Mechanisms of AMR: Mdr Genes and Antibiotics Decoys Retard the New Antibiotic Discovery against Superbugs

Asit Kumar Chakraborty
Additional contact information
Asit Kumar Chakraborty: Department of Biotechnology & Biochemistry, Oriental Institute of Science & Technology, India

Novel Approaches in Drug Designing & Development, 2017, vol. 2, issue 1, 1-5

Abstract: Many microorganisms cause lethal diseases in human causing loss of lives and property worldwide. Many antibiotics are used to cure deadly infections for the past 75 years with no difficulty. Recent outbreaks of multi-drug resistant bacteria have caused millions of death every year and physicians do not know how to cure KPC2 Klebsiella kneumoniae, NDM1 Escherichia coli or MRSA Staphylococcus aureus and XDR Acinetobacter baumannii infections. Sadly once used ampicillin, streptomycin, azithromycin, tetracycline, and chlormphenicol are useless against those bacteria. Combination therapy using colistin, imipenem, amakacin, ceftizidime and investigation drug ovibactam sometime are giving good clinical efficacy but not sure. In such a situation, heterogeneous phyto-antibiotics and gene medicines have been welcome by medical authorities but AMR calamity remains as mdr genes (amp, bla, tet, cat, aac, aad, aph,sul etc) moved to conjugative plasmids and chromosome of bacteria with target specific alterations in rRNA and porins genes.

Keywords: juniper publishers; drug designing pdf; drug designing articles; drug designing abstract; drug designing journal; modern approaches in drug designing journal; drug designing & intellectual properties international journal; peer reviewed open access journals; high impact journals; juniper publishers review (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://juniperpublishers.com/napdd/pdf/NAPDD.MS.ID.555576.pdf (application/pdf)
https://juniperpublishers.com/napdd/NAPDD.MS.ID.555576.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jnapdd:v:2:y:2017:i:1:p:1-5

DOI: 10.19080/NAPDD.2017.02.555576

Access Statistics for this article

Novel Approaches in Drug Designing & Development is currently edited by Sophia Mathis

More articles in Novel Approaches in Drug Designing & Development from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().